Targeting DNA Repair Pathways with B02 and Nocodazole Small Molecules to Improve CRIS-PITCh Mediated Cassette Integration in CHO-K1 Cells

Overview

Journal Sci Rep

Specialty Science

Date 2023 Feb 22

PMID 36813818

Authors

Behnaz Rahmani

Mohammad Hassan Kheirandish

Samaneh Ghanbari

Abbasali Raz

Fahimeh Shamsi

Fatemeh Davami

Affiliations

Soon will be listed here.

Abstract

CRISPR-mediated integration could be used to develop the recombinant CHO (rCHO) cells by knock-in into the hotspot loci. However, low HDR efficiency besides the complex donor design is the main barrier for achieving so. The recently introduced MMEJ-mediated CRISPR system (CRIS-PITCh) uses a donor with short homology arms, being linearized in the cells via two sgRNAs. In this paper, a new approach to improve CRIS-PITCh knock-in efficiency by employing small molecules was investigated. Two small molecules, B02, a Rad51 inhibitor, and Nocodazole, a G2/M cell cycle synchronizer, were used to target the S100A hotspot site using a bxb1 recombinase comprised landing pad in CHO-K1 cells. Following transfection, the CHO-K1 cells were treated with the optimum concentration of one or combination of small molecules, being determined by the cell viability or flow cytometric cell cycle assay. Stable cell lines were generated and the single-cell clones were achieved by the clonal selection procedure. The finding showed that B02 improved the PITCh-mediated integration approximately twofold. In the case of Nocodazole treatment, the improvement was even more significant, up to 2.4-fold. However, the combinatorial effects of both molecules were not substantial. Moreover, according to the copy number and out-out PCR analyses, 5 and 6 of 20 clonal cells exhibited mono-allelic integration in Nocodazole and B02 groups, respectively. The results of the present study as the first attempt to enhance the CHO platform generation by exploiting two small molecules in the CRIS-PITCh system could be used in future researches to establish rCHO clones.

Citing Articles

CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system.

Adibzadeh S, Amiri S, Barkhordari F, Mowla S, Bayat H, Ghanbari S Appl Microbiol Biotechnol. 2024; 108(1):434.

PMID: 39120640 PMC: 11315787. DOI: 10.1007/s00253-024-13266-4.

References

Alagpulinsa D, Ayyadevara S, Shmookler Reis R . A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin. Front Oncol. 2014; 4:289. PMC: 4214226. DOI: 10.3389/fonc.2014.00289. View

Aida T, Nakade S, Sakuma T, Izu Y, Oishi A, Mochida K . Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ. BMC Genomics. 2016; 17(1):979. PMC: 5126809. DOI: 10.1186/s12864-016-3331-9. View

Bachu R, Bergareche I, Chasin L . CRISPR-Cas targeted plasmid integration into mammalian cells via non-homologous end joining. Biotechnol Bioeng. 2015; 112(10):2154-62. DOI: 10.1002/bit.25629. View

Vu T, Doan D, Kim J, Sung Y, Tran M, Song Y . CRISPR/Cas-based precision genome editing via microhomology-mediated end joining. Plant Biotechnol J. 2020; 19(2):230-239. PMC: 7868975. DOI: 10.1111/pbi.13490. View

Lee J, Kallehauge T, Pedersen L, Kildegaard H . Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway. Sci Rep. 2015; 5:8572. PMC: 4339809. DOI: 10.1038/srep08572. View

Liu M, Rehman S, Tang X, Gu K, Fan Q, Chen D . Methodologies for Improving HDR Efficiency. Front Genet. 2019; 9:691. PMC: 6338032. DOI: 10.3389/fgene.2018.00691. View

Yanik M, Ponnam S, Wimmer T, Trimborn L, Muller C, Gambert I . Development of a Reporter System to Explore MMEJ in the Context of Replacing Large Genomic Fragments. Mol Ther Nucleic Acids. 2018; 11:407-415. PMC: 5992787. DOI: 10.1016/j.omtn.2018.03.010. View

Jiang F, Doudna J . CRISPR-Cas9 Structures and Mechanisms. Annu Rev Biophys. 2017; 46:505-529. DOI: 10.1146/annurev-biophys-062215-010822. View

Wierson W, Welker J, Almeida M, Mann C, Webster D, Torrie M . Efficient targeted integration directed by short homology in zebrafish and mammalian cells. Elife. 2020; 9. PMC: 7228771. DOI: 10.7554/eLife.53968. View

10.

Ronda C, Pedersen L, Hansen H, Kallehauge T, Betenbaugh M, Nielsen A . Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool. Biotechnol Bioeng. 2014; 111(8):1604-16. PMC: 4312910. DOI: 10.1002/bit.25233. View

11.

Helleday T, Petermann E, Lundin C, Hodgson B, Sharma R . DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008; 8(3):193-204. DOI: 10.1038/nrc2342. View

12.

Shkundina I, Gall A, Dick A, Cocklin S, Mazin A . New RAD51 Inhibitors to Target Homologous Recombination in Human Cells. Genes (Basel). 2021; 12(6). PMC: 8235719. DOI: 10.3390/genes12060920. View

13.

Yu W, Lescale C, Babin L, Bedora-Faure M, Lenden-Hasse H, Baron L . Repair of G1 induced DNA double-strand breaks in S-G2/M by alternative NHEJ. Nat Commun. 2020; 11(1):5239. PMC: 7567796. DOI: 10.1038/s41467-020-19060-w. View

14.

Li H, Yang Y, Hong W, Huang M, Wu M, Zhao X . Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Target Ther. 2020; 5(1):1. PMC: 6946647. DOI: 10.1038/s41392-019-0089-y. View

15.

Riesenberg S, Maricic T . Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells. Nat Commun. 2018; 9(1):2164. PMC: 5986859. DOI: 10.1038/s41467-018-04609-7. View

16.

Jang H, Song B, Hwang G, Bae S . Current trends in gene recovery mediated by the CRISPR-Cas system. Exp Mol Med. 2020; 52(7):1016-1027. PMC: 8080666. DOI: 10.1038/s12276-020-0466-1. View

17.

Lieber M . The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010; 79:181-211. PMC: 3079308. DOI: 10.1146/annurev.biochem.052308.093131. View

18.

Sawatsubashi S, Joko Y, Fukumoto S, Matsumoto T, Sugano S . Development of versatile non-homologous end joining-based knock-in module for genome editing. Sci Rep. 2018; 8(1):593. PMC: 5766535. DOI: 10.1038/s41598-017-18911-9. View

19.

Yiangou L, Grandy R, Morell C, Tomaz R, Osnato A, Kadiwala J . Method to Synchronize Cell Cycle of Human Pluripotent Stem Cells without Affecting Their Fundamental Characteristics. Stem Cell Reports. 2019; 12(1):165-179. PMC: 6335580. DOI: 10.1016/j.stemcr.2018.11.020. View

20.

Song J, Yang D, Xu J, Zhu T, Chen Y, Zhang J . RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nat Commun. 2016; 7:10548. PMC: 4738357. DOI: 10.1038/ncomms10548. View